Iterum Therapeutics Plc (ITRM) Tops Q3 EPS by 58c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.30), $0.58 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Investing.com’s stocks of the week
• Nvidia pitches Vera CPU to Chinese clients with August delivery target